有価証券レコード · アーカイブ済み四半期
BBIO
BridgeBio Pharma, Inc. · Healthcare · Biotechnology
18追跡対象保有者
-1Δ保有者数
70.97M保有株数
$3.06B報告済み評価額
+1新規ポジション
−2解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり -5.3% ·
株式フロー -3.1% ·
新規ネットポジション数 -5.6%
— 計算式
幅広い売り распределение — 株式数の減少と保有者数の縮小
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q2 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 134 | +3 | 120.77M | $8.70B | +10 | −6 |
| Q1 2026 | 133 | +3 | 129.51M | $9.40B | +8 | −6 |
| Q4 2025 | 129 | +2 | 135.35M | $9.88B | +4 | −1 |
| Q3 2025 | 19 | -1 | 71.67M | $3.72B | — | −2 |
| Q2 2025 | 18 | -1 | 70.97M | $3.06B | +1 | −2 |
| Q1 2025 | 16 | +3 | 40.50M | $1.40B | +3 | — |
| Q4 2024 | 13 | 0 | 40.68M | $1.12B | +1 | −1 |
| Q3 2024 | 12 | -1 | 35.94M | $914.95M | — | −1 |
| Q2 2024 | 13 | — | 36.42M | $922.50M | — | — |
保有者情報 · Q2 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 18.56M | -15.9% | $801.22M | 2.3% | ▼ Trim | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (パッシブ) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (パッシブ) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (パッシブ) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (パッシブ) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (パッシブ) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (パッシブ) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (パッシブ) | 5.90M | +2.6% | $254.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (パッシブ) | 5.90M | +2.6% | $254.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | Geode Capital Management ✦ (パッシブ) | 3.68M | +5.1% | $158.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Geode Capital Management ✦ (パッシブ) | 3.68M | +5.1% | $158.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 2.34M | +177.4% | $101.00M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 2.08M | +2403.0% | $89.87M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 2.08M | +2403.0% | $89.87M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Norges Bank ✦ (パッシブ) | 1.96M | +57.2% | $84.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 961.22K | -17.5% | $41.51M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | T. Rowe Price ✦ | 961.22K | -17.5% | $41.51M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Millennium Management ✦ | 620.46K | +158.6% | $26.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | Millennium Management ✦ | 620.46K | +158.6% | $26.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | PRIMECAP Management ✦ | 588.71K | -35.5% | $25.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Marshall Wace ✦ | 422.71K | +0.2% | $18.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Marshall Wace ✦ | 422.71K | +0.2% | $18.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Citadel Advisors ✦ | 332.32K | -88.7% | $14.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | Citadel Advisors ✦ | 332.32K | -88.7% | $14.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | Citadel Advisors ✦ | 332.32K | -88.7% | $14.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 49 | Adage Capital Partners ✦ | 301.36K | -41.7% | $13.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 50 | Renaissance Technologies ✦ | 245.95K | 新規 | $10.62M | 0.0% | New | 1 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 56 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 57 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 58 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 59 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| Renaissance Technologies | $10.62M | 0.0% |
ポジション解消済み
| Duquesne Family Office | $15.14M | だった 0.5% |
| Point72 Asset Management | $6.87M | だった 0.0% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 1 保有者, 15.30K 株式数, $1,136 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。
市場内買い付け (P)
カバレッジ期間内にインサイダーによる市場内買い付けはありません。
市場内売却 (S)
Aug 19
Kumar Neil
Officer, Director · 8.10K 株 · $679,256
Aug 19
Kumar Neil
Officer, Director · 1.80K 株 · $152,436
Aug 19
Kumar Neil
Officer, Director · 100 株 · $8,565
Aug 18
Kumar Neil
Officer, Director · 17.28K 株 · $1.42M
Aug 18
Kumar Neil
Officer, Director · 1.90K 株 · $154,184
Aug 18
Kumar Neil
Officer, Director · 14.60K 株 · $1.21M
Aug 18
Kumar Neil
Officer, Director · 1.20K 株 · $100,444
株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。 方法論
Aug 17
SC 13D/A — KKR Genetic Disorder L.P.
4.2% クラスの · SECオリジナル提出書類を表示 ↗
Aug 03
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 27
SC 13G/A — BlackRock, Inc.
Jul 10
SC 13D/A — VIKING GLOBAL INVESTORS LP
5.0% クラスの · SECオリジナル提出書類を表示 ↗
May 29
SC 13G — Farallon Capital Partners, L.P.